KRAS and colorectal cancer: Analogously, in KRAS-mutated colorectal cancer, where ICI is ineffective, expression of key chemokines involved in IFN network signaling, such as CXCL3, are downregulated when KRAS is mutated due to direct interaction with IRF239.